-mustine
Nitrogen mustard alkylating agents for cancer.
- Drugs ending in -mustine: 13
- Approved somewhere: 4
- With a US drug page: 5
- Stem
- -mustine
- Class
- Nitrogen mustard alkylating agents for cancer
Approved and clinical-stage drugs in ChEMBL whose names ending in -mustine, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Bendamustine | Approved | DNA | DNA inhibitor |
| Carmustine | Approved | GSR, DNA, RNA | Glutathione reductase inhibitor |
| Estramustine phosphate | Approved | ESR2, DNA | Estrogen receptor beta modulator |
| Lomustine | Approved | DNA | DNA inhibitor |
| Estramustine | Phase 3 | — | — |
| Fotemustine | Phase 3 | DNA | DNA cross-linking agent |
| Laromustine | Phase 3 | DNA | DNA cross-linking agent |
| Ranimustine | Phase 3 | — | — |
| Semustine | Phase 3 | DNA | DNA cross-linking agent |
| Nimustine | Phase 2 | DNA | DNA disrupting agent |
| Prednimustine | Phase 2 | — | — |
| Bendamustine dodecyl ester | Phase 1 | — | — |
| Tinostamustine | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO